Keywords
obesity, antibiotics, antibiotic therapy, probiotics, evidence-based research
How to Cite
Plotnikova, E. Y., & Zakharova, Y. V. (2019). Antibiotics as modulators of the intestinal microbiota: between good and evil. Herald of Pancreatic Club, 42(1), 63-72. https://doi.org/10.33149/vkp.2019.01.09
Abstract views: 547 PDF Downloads: 384 PDF Downloads: 266
Abstract
In some countries of the world, the prevalence of obesity is increasing at the rate of an epidemic. A significant role in the staying healthy, strengthening immunity and normalizing metabolism is assigned to microbes. Among the drugs that are used to treat serious infectious diseases, antibiotics dominate as the drugs that keep on saving precious human lives. The side effects of antibiotic therapy on the intestinal microflora range from self-leveling and fast-passing “functional” diarrhea to life-threatening pseudomembranous colitis. Recently conducted epidemiological studies have shown that antibiotics are associated with a high risk of weight gain and the development of obesity. Violation of the intestinal microflora is caused not only by antibiotic therapy, but also by the intake of a number of products. Antibacterial drugs are widely used in agriculture as growth promoters, they are stored in the meat of animals and poultry that we eat. Obesity has been proven to be associated with a dysbiotic shift in the fecal microbiota and a low content of bifidobacteria. The hypothesis according to which the intestinal microbiota is a potentially variable target for the prevention and/or treatment of obesity is described in detail. Probiotics are agents capable of modulating and improving the intestinal microflora during antibiotic therapy. The review presents data demonstrating the ability of probiotics not only to prevent the development of dysbiosis that occurs when using antibiotics, but also to impede the emergence of overweight and obesity.
References
1. Война миров: антибиотики в сельском хозяйстве. TheDairyNews. URL: http://www.dairynews.ru/dairyfarm/voyna-mirov-antibiotiki-v-selskom-khozyaystve.html(дата обращения: 19.10.2018).
2. Гриневич В. Б., Сас Е. И. Физиологические эффекты желчных кислот. РМЖ «Медицинское обозрение». 2017. № 2. С. 87–91.
3. Плотникова Е. Ю., Краснов О. А. Метаболический синдром и кишечная микрофлора; что общего? Экспериментальная и клиническая гастроэнтерология. 2015. № 112 (12). С. 64–73.
4. Acar J., Casewell M., Freeman J., Friis C., Goossens H. Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making. Clin. Microbiol. Infect. 2000. Vol. 6. P. 477–482.
5. Ajslev T. A., Andersen C. S., Gamborg M., Sørensen T. I. A., Jess T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int. J. Obes. 2011. Vol. 35. P. 522–529.
6. Alcock J., Maley C. C., Aktipis C. A. Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. Bioessays. 2014. Vol. 36, No 10. P. 940–949.
7. Angelakis E. Weight gain by gut microbiota manipulation in productive animals. Microb. Pathog. 2017. Vol. 106. P. 162–170.
8. Azad M. B., Bridgman S. L., Becker A. B., Kozyrskyj A. L. Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int. J. Obes. 2014. Vol. 38. P. 1290–1298.
9. Backhed F., Ding H., Wang T., Hooper L. V., Koh G. Y., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA. 2004. Vol. 101. P. 15718–15723.
10. Bäckhed F., Ley R. E., Sonnenburg J. L., Peterson D. A., Gordon J. I. Host-bacterial mutualism in the human intestine. Science. 2005. Vol. 307. P. 1915–1920.
11. Bailey L. C. Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr. 2014. Vol. 168, No 11. P. 1063–1069.
12. Beaugerie L., Petit J. C. Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. Best Pract. Res. Clin. Gastroenterol. 2004. Vol. 18. P. 337–352.
13. Blaser M. J. Missing microbes: how the overuse of antibiotics is fueling our modern plagues. New York: Henry Holt and Company, 2014. 288 р.
14. BlaserM. J. Слайд-шоу из лекции «Антибиотики и ожирение». URL: https://www.amnh.org/explore/science-topics/health-and-our-microbiome/meet-your-microbiome (дата обращения: 19.10.2018).
15. Blaser M. J., Falkow S. What are the consequences of the disappearing human microbiota? Nat. Rev. Micro. 2009. Vol. 7. P. 887–894.
16. Blustein J. Association of caesarean delivery with child adiposity from age 6 weeks to 15 years. Int. J. Obes. 2013. Vol. 37. P. 900–906.
17. Borgeraas H., Johnson L. K., Skattebu J., Hertel J. K., Hjelmesæth J. Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2018 Vol. 19, No 2. P. 219–232.
18. Broe A., Pottegård A., Lamont R. F., Jørgensen J. S., Damkier P. Increasing use of antibiotics in pregnancy during the period 2000–2010: prevalence, timing, category, and demographics. BJOG. 2014. Vol. 121. P. 988–996.
19. Butaye P., Devriese L., Haesebrouck F. Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria. Clin. Microbiol. Rev. 2003. Vol. 16. P. 175–188.
20. Cani P. D., Lecourt E., Dewulf E. M. et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am. J. Clin. Nutr. 2009. Vol. 90, No 5. P. 1236–1243.
21. Chatelier E., Nielsen T., Qin J., Prifti E., Hildebrand F., Falony G. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013. Vol. 500. P. 541–546
22. Cho I., Yamanishi S., Cox L., Methe B. A., Zavadil J., Li K., Gao Z., Mahana D., Raju K., Teitler I., et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 2012. Vol. 488. P. 621–626.
23. Coates M. E., Fuller R., Harrison G. F., Lev M., Suffolk S. F. A comparison of the growth of chicks in the Gustafsson germ-free apparatus and in a conventional environment, with and without dietary supplements of penicillin. Br. J. Nutr. 1963. Vol. 17. P. 141–150.
24. Collaboration NCDRF. Trends in adult body mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016. Vol. 387, No 10026. P. 1377–1396.
25. Cotillard A., Kennedy S. P., Kong L. C., et al. Dietary intervention impact on gut microbial gene richness. Nature. 2013. Vol. 500, No 7464. P. 585–588.
26. Cox L. M., Blaser M. J. Antibiotics in early life and obesity. Nat. Rev. Endocrinol. 2015. Vol. 11, No 3. P. 182–190.
27. Dethlefsen L., Huse S., Sogin M. L., Relman D. A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008. Vol. 6. P. e280.
28. Dethlefsen L., McFall-Ngai M., Relman D. A. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature. 2007. Vol. 449. P. 811–818.
29. Dethlefsen L., Relman D. A. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. USA. 2011. Vol. 108, Suppl. 1. P. 4554–6110.
30. Dominguez-Bello M. G., Blaser M. J., Ley R. E., Knight R. Development of the human gastrointestinal microbiota and insights from high-throughput sequencing. Gastroenterology. 2011. Vol. 140. P. 1713–1719.
31. Donoghue D. J. Antibiotic residues in poultry tissues and eggs: human health concerns? Poultry Sci. 2003. Vol. 82. P. 618–621.
32. Drissi F., Raoult D., Merhej V. Metabolic role of lactobacilli in weight modification in humans and animals. Microb. Pathog. 2016. Vol. 106. P. 182–194.
33. Dyer I. A., Koes R. M., Herlugson M. L., Ojikutu L. B., Preston R. L., et al. Effect of avoparcin and monensin on performance of finishing heifers. J. Anim. Sci. 1980. Vol. 51. P. 843–846.
34. Eloe-Fadrosh E. A., Brady A., Crabtree J., et al. Functional dynamics of the gut microbiome in elderly people during probiotic consumption. MBio. 2015. Vol. 6, No 2. P. 1–12.
35. Feighner S. D., Dashkevicz M. P. Subtherapeutic levels of antibiotics in poultry feeds and their effects on weight gain, feed efficiency, and bacterial cholyltaurine hydrolase activity. Appl. Environ Microbiol. 1987. Vol. 53. P. 331–336.
36. Finkelstein E. A., Graham W. C. K., Malhotra R. Lifetime direct medical costs of childhood obesity. Pediatrics. 2014. Vol. 133. P. 1–9.
37. Fridkin S. Vital signs: improving antibiotic use among hospitalized patients. MMWR. Morbidity and mortality weekly report. 2014. Vol. 63. P. 194–200.
38. Gaskins H., Collier C., Anderson D. Antibiotics as growth promotants: mode of action. Anim. Biotechnol. 2002. Vol. 13. P. 29–42.
39. Gerber J. S. Variation in antibiotic prescribing across a pediatric primary care network. J. Pediatric Infect. Dis. Soc. 2015. Vol. 4, No 4. P. 297–304.
40. Grijalva C. G., Nuorti J., Griffin M. R. Antibiotic prescription rates for acute respiratory tract infections in us ambulatory settings. JAMA. 2009. Vol. 302. P. 758–766.
41. Hayes A., Chevalier A., D’Souza M., Baur L., Wen L. M., Simpson J. Early childhood obesity: association with healthcare expenditure in Australia. Obesity. 2016. Vol. 24, No 8. P. 1752–1758.
42. He M., Shi B. Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. Cell Biosci. 2017. Vol. 7. P. 54.
43. Hersh A. L., Jackson M. A., Hicks L. A. Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics. 2013. Vol. 132. P. 1146–1154.
44. Hicks L. A., Taylor T. H., Hunkler R. J. US. Outpatient Antibiotic Prescribing. 2010. New Engl. J. Med. 2013. Vol. 368. P. 1461–1462.
45. Hooper L. V., Littman D. R., Macpherson A. J. Interactions between the microbiota and the immune system. Science. 2012. Vol. 336. P. 1268–1273.
46. Huh S. Y., Rifas-Shiman S. L., Zera C. A., Edwards J. W. R., Oken E., Weiss S. T., Gillman M. W. Delivery by caesarean section and risk of obesity in preschool age children: a prospective cohort study. Arch. Dis. Childhood. 2012. Vol. 97. P. 610–616.
47. Jepsen P. A population-based study of maternal use of amoxicillin and pregnancy outcome in Denmark. British Journal of Clinical Pharmacology. 2003. Vol. 55. P. 216–221.
48. Jukes T. H., Williams W. L. Nutritional effects of antibiotics. Pharmacol Rev. 1953. Vol. 5. P. 381–420.
49. Kadooka Y., Sato M., Imaizumi K., Ogawa A., Ikuyama K., Akai Y., Okano M., Kagoshima M., Tsuchida T. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur. J. Clin. Nutr. 2010. Vol. 64, No 6. P. 636–643.
50. Lee G. C. Outpatient antibiotic prescribing in the United States: 2000 to 2010. BMC medicine. 2014. Vol. 12. P. 96.
51. Ley R. E., Backhed F., Turnbaugh P., Lozupone C. A., Knight R. D., Gordon J. I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA. 2005. Vol. 102, No 31. P. 11070–11075.
52. Lofmark S., Jernberg C., Billstrom H., Andersson D. I., Edlund C. Restored fitness leads to long-term persistence of resistant Bacteroides strains in the human intestine. Anaerobe. 2008. Vol. 14. P. 157–160.
53. Marra F., Lynd L., Coombes M., Richardson K., Legal M., et al. Does antibiotic exposure during infancy lead to development of asthma?A systematic review and metaanalysis. Chest. 2006. Vol. 129. P. 610–618.
54. Marshall B. M., Levy S. B. Food animals and antimicrobials: impacts on human health. Clin. Microbiol. Rev. 2011. Vol. 24. P. 718–733.
55. McCaig L. F., Besser R. E., Hughes J. M. Trends in antimicrobial prescribing rates for children and adolescents. JAMA. 2002. Vol. 287. P. 3096–3102.
56. McGarr S. E., Ridlon J. M., Hylemon P. B. Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature. J. Clin. Gastroenterol. 2005. Vol. 39. P. 98–109.
57. McNulty N. P., Yatsunenko T., Hsiao A., et al. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci. Transl. Med. 2011. Vol. 3, No 106.
58. Moriarty J. P., Branda M. E., Olsen K. D., Shah N. D., Borah B. J., Wagie A. E., Egginton J. S., Naessens J. M. The effects of incremental costs of smoking and obesity on health care costs among adults. Journal of Occupational and Environmental Medicine. 2012. Vol. 54, No 3. P. 286.
59. Mueller N. T., Whyatt R., Hoepner L., Oberfield S., Dominguez-Bello M. G., Widen E. M., Hassoun A., Perera F., Rundle A. Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Int. J. Obes. 2015. Vol. 39, No 4. P. 665–670.
60. Muir L. A. Mode of action of exogenous substances on animal growth — an overview. Journal of animal science. 1985. Vol. 61. P. 154–180.
61. Murphy R. Antibiotic treatment during infancy and increased body mass index in boys: an international cross-sectional study. Int. J. Obes. 2013. Vol. 38. P. 115–119.
62. Nestle M. Food politics: how the food industry influences nutrition and health. Berkeley: Un-ty of California, 2002. 457 р.
63. Ng M., Fleming T., Robinson M., et al. Global, regional and national prevalence of overweight and obesity in children and adults 1980–2013: a systematic analysis. Lancet. 2014. Vol. 384, No 9945. P. 766–781.
64. Nicholson J. K., Holmes E., Wilson I. D. Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol. 2005. Vol. 3. P. 431–438.
65. Nieuwdorp M., Gilijamse P. W., Pai N., Kaplan L. M. Role of the microbiome in energy regulation and metabolism. Gastroenterology. 2014. Vol. 146, No 6. P. 1525–1533.
66. Noverr M. C., Huffnagle G. B. The ‘microflora hypothesis’ of allergic diseases. Clin. Exp. Allergy. 2005. Vol. 35. P. 1511–1520.
67. O’Keefe S. J., Chung D., Mahmoud N., Sepulveda A. R., Manafe M., et al. Why do African Americans get more colon cancer than Native Africans.J. Nutr. 2007. Vol. 137. P. 175S–182S.
68. Parikh N. I., Pencina M. J., Wang T. J., Lanier K. J., Fox C. S., D’Agostino R. B., Vasan R. S. Increasing trends in incidence of overweight and obesity over 5 decades. Am. J. Med. 2007 Mar. Vol. 120, No 3. P. 242–250.
69. Prioult G., Nagler-Anderson C. Mucosal immunity and allergic responses: lack of regulation and/or lack of microbial stimulation. Immunol. Rev. 2005. Vol. 206. P. 204–218.
70. Riley L. W., Raphael E., Faerstein E. Obesity in the United States — dysbiosis from exposure to low-dose antibiotics? Front Public Health. 2013. P. 1–8.
71. Sanders M. E. Probiotics and microbiota composition. BMC Med. 2016. Vol. 14, No 1. P. 82.
72. Sayin S. I., Wahlstrom A., Felin J., et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013. Vol. 17, No 2. P. 225–235.
73. Sjolund M., Wreiber K., Andersson D. I., Blaser M. J., Engstrand L. Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori. Ann. Intern. Med.2003. Vol. 139. P. 483–487.
74. Stewart C. S., Duncan S. H., Cave D. R. Oxalobacter formigenes and its role in oxalate metabolism in the human gut. FEMS Microbiol. Lett. 2004. Vol. 230. P. 1–7.
75. Sullivan A., Edlund C., Nord C. E. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect. Dis. 2001. Vol. 1. P. 101–114.
76. Taylor J. H., Gordon W. S. Growth-promoting activity for pigs of inactivated penicillin. Nature. 1955. Vol. 176. P. 312–313.
77. Ternak G. Antibiotics may act as growth/obesity promoters in humans as an inadvertent result of antibiotic pollution? Medical Hypotheses. 2005. Vol. 64. P. 14–16.
78. Ternhag A., Hellman J. More on U.S. outpatient antibiotic prescribing. 2010. New Engl. J. Med. 2013. Vol. 369. P. 1175–1176.
79. Thuny F., Richet H., Casalta J.-P., Angelakis E., Habib G., Raoult D. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS One. 2010. Vol. 5, No 2. P. e9074.
80. Trasande L., Blustein J., Liu M., Corwin E., Cox L. M., Blaser M. J. Infant antibiotic exposures and early-life body mass. Int. J. Obes. 2013. Vol. 37. P. 16–23.
81. Tremaroli V., Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012. Vol. 489, No 7415. P. 242–249.
82. Turnbaugh P. J., Ley R. E., Mahowald M. A., Magrini V., Mardis E. R., Gordon J. I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006. Vol. 444, No 7122. P. 1027–1031.
83. Van Boeckel T. P., Brower C., Gilbert M., Grenfell B. T., Levin S. A., Robinson T. P., Teillant A., Laxminarayan R. Global trends in antimicrobial use in food animals. Proc. Natl. Acad. Sci. USA. Vol. 112, No 18. P. 5649–5654.
84. Vidal A. C. Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring. Int. J. Obes. 2013. Vol. 37. P. 907–913.
85. Watanabe M., Morimoto K., Houten S. M., et al. Bile acid binding resin improves metabolic control through the induction of energy expenditure. PLoS One. 2012. Vol. 7, No 8. P. e38286.
86. Wilcox M. H. Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis. Best Pract. Res. Clin. Gastroenterol. 2003. Vol. 17. P. 475–493.
87. Zhang Q., Wu Y., Fei X. Effect of probiotics on body weight and bodymass index: a systematic review and meta-analysis of randomized, controlled trials. Int. J. Food Sci. Nutr. 2015. Vol. 67, No 5. P. 571–580.
2. Гриневич В. Б., Сас Е. И. Физиологические эффекты желчных кислот. РМЖ «Медицинское обозрение». 2017. № 2. С. 87–91.
3. Плотникова Е. Ю., Краснов О. А. Метаболический синдром и кишечная микрофлора; что общего? Экспериментальная и клиническая гастроэнтерология. 2015. № 112 (12). С. 64–73.
4. Acar J., Casewell M., Freeman J., Friis C., Goossens H. Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making. Clin. Microbiol. Infect. 2000. Vol. 6. P. 477–482.
5. Ajslev T. A., Andersen C. S., Gamborg M., Sørensen T. I. A., Jess T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int. J. Obes. 2011. Vol. 35. P. 522–529.
6. Alcock J., Maley C. C., Aktipis C. A. Is eating behavior manipulated by the gastrointestinal microbiota? Evolutionary pressures and potential mechanisms. Bioessays. 2014. Vol. 36, No 10. P. 940–949.
7. Angelakis E. Weight gain by gut microbiota manipulation in productive animals. Microb. Pathog. 2017. Vol. 106. P. 162–170.
8. Azad M. B., Bridgman S. L., Becker A. B., Kozyrskyj A. L. Infant antibiotic exposure and the development of childhood overweight and central adiposity. Int. J. Obes. 2014. Vol. 38. P. 1290–1298.
9. Backhed F., Ding H., Wang T., Hooper L. V., Koh G. Y., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA. 2004. Vol. 101. P. 15718–15723.
10. Bäckhed F., Ley R. E., Sonnenburg J. L., Peterson D. A., Gordon J. I. Host-bacterial mutualism in the human intestine. Science. 2005. Vol. 307. P. 1915–1920.
11. Bailey L. C. Association of antibiotics in infancy with early childhood obesity. JAMA Pediatr. 2014. Vol. 168, No 11. P. 1063–1069.
12. Beaugerie L., Petit J. C. Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. Best Pract. Res. Clin. Gastroenterol. 2004. Vol. 18. P. 337–352.
13. Blaser M. J. Missing microbes: how the overuse of antibiotics is fueling our modern plagues. New York: Henry Holt and Company, 2014. 288 р.
14. BlaserM. J. Слайд-шоу из лекции «Антибиотики и ожирение». URL: https://www.amnh.org/explore/science-topics/health-and-our-microbiome/meet-your-microbiome (дата обращения: 19.10.2018).
15. Blaser M. J., Falkow S. What are the consequences of the disappearing human microbiota? Nat. Rev. Micro. 2009. Vol. 7. P. 887–894.
16. Blustein J. Association of caesarean delivery with child adiposity from age 6 weeks to 15 years. Int. J. Obes. 2013. Vol. 37. P. 900–906.
17. Borgeraas H., Johnson L. K., Skattebu J., Hertel J. K., Hjelmesæth J. Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2018 Vol. 19, No 2. P. 219–232.
18. Broe A., Pottegård A., Lamont R. F., Jørgensen J. S., Damkier P. Increasing use of antibiotics in pregnancy during the period 2000–2010: prevalence, timing, category, and demographics. BJOG. 2014. Vol. 121. P. 988–996.
19. Butaye P., Devriese L., Haesebrouck F. Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria. Clin. Microbiol. Rev. 2003. Vol. 16. P. 175–188.
20. Cani P. D., Lecourt E., Dewulf E. M. et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am. J. Clin. Nutr. 2009. Vol. 90, No 5. P. 1236–1243.
21. Chatelier E., Nielsen T., Qin J., Prifti E., Hildebrand F., Falony G. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013. Vol. 500. P. 541–546
22. Cho I., Yamanishi S., Cox L., Methe B. A., Zavadil J., Li K., Gao Z., Mahana D., Raju K., Teitler I., et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature. 2012. Vol. 488. P. 621–626.
23. Coates M. E., Fuller R., Harrison G. F., Lev M., Suffolk S. F. A comparison of the growth of chicks in the Gustafsson germ-free apparatus and in a conventional environment, with and without dietary supplements of penicillin. Br. J. Nutr. 1963. Vol. 17. P. 141–150.
24. Collaboration NCDRF. Trends in adult body mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants. Lancet. 2016. Vol. 387, No 10026. P. 1377–1396.
25. Cotillard A., Kennedy S. P., Kong L. C., et al. Dietary intervention impact on gut microbial gene richness. Nature. 2013. Vol. 500, No 7464. P. 585–588.
26. Cox L. M., Blaser M. J. Antibiotics in early life and obesity. Nat. Rev. Endocrinol. 2015. Vol. 11, No 3. P. 182–190.
27. Dethlefsen L., Huse S., Sogin M. L., Relman D. A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008. Vol. 6. P. e280.
28. Dethlefsen L., McFall-Ngai M., Relman D. A. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature. 2007. Vol. 449. P. 811–818.
29. Dethlefsen L., Relman D. A. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. USA. 2011. Vol. 108, Suppl. 1. P. 4554–6110.
30. Dominguez-Bello M. G., Blaser M. J., Ley R. E., Knight R. Development of the human gastrointestinal microbiota and insights from high-throughput sequencing. Gastroenterology. 2011. Vol. 140. P. 1713–1719.
31. Donoghue D. J. Antibiotic residues in poultry tissues and eggs: human health concerns? Poultry Sci. 2003. Vol. 82. P. 618–621.
32. Drissi F., Raoult D., Merhej V. Metabolic role of lactobacilli in weight modification in humans and animals. Microb. Pathog. 2016. Vol. 106. P. 182–194.
33. Dyer I. A., Koes R. M., Herlugson M. L., Ojikutu L. B., Preston R. L., et al. Effect of avoparcin and monensin on performance of finishing heifers. J. Anim. Sci. 1980. Vol. 51. P. 843–846.
34. Eloe-Fadrosh E. A., Brady A., Crabtree J., et al. Functional dynamics of the gut microbiome in elderly people during probiotic consumption. MBio. 2015. Vol. 6, No 2. P. 1–12.
35. Feighner S. D., Dashkevicz M. P. Subtherapeutic levels of antibiotics in poultry feeds and their effects on weight gain, feed efficiency, and bacterial cholyltaurine hydrolase activity. Appl. Environ Microbiol. 1987. Vol. 53. P. 331–336.
36. Finkelstein E. A., Graham W. C. K., Malhotra R. Lifetime direct medical costs of childhood obesity. Pediatrics. 2014. Vol. 133. P. 1–9.
37. Fridkin S. Vital signs: improving antibiotic use among hospitalized patients. MMWR. Morbidity and mortality weekly report. 2014. Vol. 63. P. 194–200.
38. Gaskins H., Collier C., Anderson D. Antibiotics as growth promotants: mode of action. Anim. Biotechnol. 2002. Vol. 13. P. 29–42.
39. Gerber J. S. Variation in antibiotic prescribing across a pediatric primary care network. J. Pediatric Infect. Dis. Soc. 2015. Vol. 4, No 4. P. 297–304.
40. Grijalva C. G., Nuorti J., Griffin M. R. Antibiotic prescription rates for acute respiratory tract infections in us ambulatory settings. JAMA. 2009. Vol. 302. P. 758–766.
41. Hayes A., Chevalier A., D’Souza M., Baur L., Wen L. M., Simpson J. Early childhood obesity: association with healthcare expenditure in Australia. Obesity. 2016. Vol. 24, No 8. P. 1752–1758.
42. He M., Shi B. Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. Cell Biosci. 2017. Vol. 7. P. 54.
43. Hersh A. L., Jackson M. A., Hicks L. A. Principles of judicious antibiotic prescribing for upper respiratory tract infections in pediatrics. Pediatrics. 2013. Vol. 132. P. 1146–1154.
44. Hicks L. A., Taylor T. H., Hunkler R. J. US. Outpatient Antibiotic Prescribing. 2010. New Engl. J. Med. 2013. Vol. 368. P. 1461–1462.
45. Hooper L. V., Littman D. R., Macpherson A. J. Interactions between the microbiota and the immune system. Science. 2012. Vol. 336. P. 1268–1273.
46. Huh S. Y., Rifas-Shiman S. L., Zera C. A., Edwards J. W. R., Oken E., Weiss S. T., Gillman M. W. Delivery by caesarean section and risk of obesity in preschool age children: a prospective cohort study. Arch. Dis. Childhood. 2012. Vol. 97. P. 610–616.
47. Jepsen P. A population-based study of maternal use of amoxicillin and pregnancy outcome in Denmark. British Journal of Clinical Pharmacology. 2003. Vol. 55. P. 216–221.
48. Jukes T. H., Williams W. L. Nutritional effects of antibiotics. Pharmacol Rev. 1953. Vol. 5. P. 381–420.
49. Kadooka Y., Sato M., Imaizumi K., Ogawa A., Ikuyama K., Akai Y., Okano M., Kagoshima M., Tsuchida T. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur. J. Clin. Nutr. 2010. Vol. 64, No 6. P. 636–643.
50. Lee G. C. Outpatient antibiotic prescribing in the United States: 2000 to 2010. BMC medicine. 2014. Vol. 12. P. 96.
51. Ley R. E., Backhed F., Turnbaugh P., Lozupone C. A., Knight R. D., Gordon J. I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA. 2005. Vol. 102, No 31. P. 11070–11075.
52. Lofmark S., Jernberg C., Billstrom H., Andersson D. I., Edlund C. Restored fitness leads to long-term persistence of resistant Bacteroides strains in the human intestine. Anaerobe. 2008. Vol. 14. P. 157–160.
53. Marra F., Lynd L., Coombes M., Richardson K., Legal M., et al. Does antibiotic exposure during infancy lead to development of asthma?A systematic review and metaanalysis. Chest. 2006. Vol. 129. P. 610–618.
54. Marshall B. M., Levy S. B. Food animals and antimicrobials: impacts on human health. Clin. Microbiol. Rev. 2011. Vol. 24. P. 718–733.
55. McCaig L. F., Besser R. E., Hughes J. M. Trends in antimicrobial prescribing rates for children and adolescents. JAMA. 2002. Vol. 287. P. 3096–3102.
56. McGarr S. E., Ridlon J. M., Hylemon P. B. Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature. J. Clin. Gastroenterol. 2005. Vol. 39. P. 98–109.
57. McNulty N. P., Yatsunenko T., Hsiao A., et al. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci. Transl. Med. 2011. Vol. 3, No 106.
58. Moriarty J. P., Branda M. E., Olsen K. D., Shah N. D., Borah B. J., Wagie A. E., Egginton J. S., Naessens J. M. The effects of incremental costs of smoking and obesity on health care costs among adults. Journal of Occupational and Environmental Medicine. 2012. Vol. 54, No 3. P. 286.
59. Mueller N. T., Whyatt R., Hoepner L., Oberfield S., Dominguez-Bello M. G., Widen E. M., Hassoun A., Perera F., Rundle A. Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity. Int. J. Obes. 2015. Vol. 39, No 4. P. 665–670.
60. Muir L. A. Mode of action of exogenous substances on animal growth — an overview. Journal of animal science. 1985. Vol. 61. P. 154–180.
61. Murphy R. Antibiotic treatment during infancy and increased body mass index in boys: an international cross-sectional study. Int. J. Obes. 2013. Vol. 38. P. 115–119.
62. Nestle M. Food politics: how the food industry influences nutrition and health. Berkeley: Un-ty of California, 2002. 457 р.
63. Ng M., Fleming T., Robinson M., et al. Global, regional and national prevalence of overweight and obesity in children and adults 1980–2013: a systematic analysis. Lancet. 2014. Vol. 384, No 9945. P. 766–781.
64. Nicholson J. K., Holmes E., Wilson I. D. Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol. 2005. Vol. 3. P. 431–438.
65. Nieuwdorp M., Gilijamse P. W., Pai N., Kaplan L. M. Role of the microbiome in energy regulation and metabolism. Gastroenterology. 2014. Vol. 146, No 6. P. 1525–1533.
66. Noverr M. C., Huffnagle G. B. The ‘microflora hypothesis’ of allergic diseases. Clin. Exp. Allergy. 2005. Vol. 35. P. 1511–1520.
67. O’Keefe S. J., Chung D., Mahmoud N., Sepulveda A. R., Manafe M., et al. Why do African Americans get more colon cancer than Native Africans.J. Nutr. 2007. Vol. 137. P. 175S–182S.
68. Parikh N. I., Pencina M. J., Wang T. J., Lanier K. J., Fox C. S., D’Agostino R. B., Vasan R. S. Increasing trends in incidence of overweight and obesity over 5 decades. Am. J. Med. 2007 Mar. Vol. 120, No 3. P. 242–250.
69. Prioult G., Nagler-Anderson C. Mucosal immunity and allergic responses: lack of regulation and/or lack of microbial stimulation. Immunol. Rev. 2005. Vol. 206. P. 204–218.
70. Riley L. W., Raphael E., Faerstein E. Obesity in the United States — dysbiosis from exposure to low-dose antibiotics? Front Public Health. 2013. P. 1–8.
71. Sanders M. E. Probiotics and microbiota composition. BMC Med. 2016. Vol. 14, No 1. P. 82.
72. Sayin S. I., Wahlstrom A., Felin J., et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 2013. Vol. 17, No 2. P. 225–235.
73. Sjolund M., Wreiber K., Andersson D. I., Blaser M. J., Engstrand L. Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori. Ann. Intern. Med.2003. Vol. 139. P. 483–487.
74. Stewart C. S., Duncan S. H., Cave D. R. Oxalobacter formigenes and its role in oxalate metabolism in the human gut. FEMS Microbiol. Lett. 2004. Vol. 230. P. 1–7.
75. Sullivan A., Edlund C., Nord C. E. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect. Dis. 2001. Vol. 1. P. 101–114.
76. Taylor J. H., Gordon W. S. Growth-promoting activity for pigs of inactivated penicillin. Nature. 1955. Vol. 176. P. 312–313.
77. Ternak G. Antibiotics may act as growth/obesity promoters in humans as an inadvertent result of antibiotic pollution? Medical Hypotheses. 2005. Vol. 64. P. 14–16.
78. Ternhag A., Hellman J. More on U.S. outpatient antibiotic prescribing. 2010. New Engl. J. Med. 2013. Vol. 369. P. 1175–1176.
79. Thuny F., Richet H., Casalta J.-P., Angelakis E., Habib G., Raoult D. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS One. 2010. Vol. 5, No 2. P. e9074.
80. Trasande L., Blustein J., Liu M., Corwin E., Cox L. M., Blaser M. J. Infant antibiotic exposures and early-life body mass. Int. J. Obes. 2013. Vol. 37. P. 16–23.
81. Tremaroli V., Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012. Vol. 489, No 7415. P. 242–249.
82. Turnbaugh P. J., Ley R. E., Mahowald M. A., Magrini V., Mardis E. R., Gordon J. I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006. Vol. 444, No 7122. P. 1027–1031.
83. Van Boeckel T. P., Brower C., Gilbert M., Grenfell B. T., Levin S. A., Robinson T. P., Teillant A., Laxminarayan R. Global trends in antimicrobial use in food animals. Proc. Natl. Acad. Sci. USA. Vol. 112, No 18. P. 5649–5654.
84. Vidal A. C. Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring. Int. J. Obes. 2013. Vol. 37. P. 907–913.
85. Watanabe M., Morimoto K., Houten S. M., et al. Bile acid binding resin improves metabolic control through the induction of energy expenditure. PLoS One. 2012. Vol. 7, No 8. P. e38286.
86. Wilcox M. H. Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis. Best Pract. Res. Clin. Gastroenterol. 2003. Vol. 17. P. 475–493.
87. Zhang Q., Wu Y., Fei X. Effect of probiotics on body weight and bodymass index: a systematic review and meta-analysis of randomized, controlled trials. Int. J. Food Sci. Nutr. 2015. Vol. 67, No 5. P. 571–580.